zealand pharma a/s (ZEAL:Copenhagen)

Financial Statements for zealand pharma a/s (ZEAL)

Currency in Millions of Danish Krones	As of:	Dec 31 2009 Restated DKK	Dec 31 2010 Reclassified DKK	Dec 31 2011 Restated DKK	Dec 31 2012 DKK	4 Year Trend
Revenues		25.3	87.4	142.3	223.6
TOTAL REVENUES		25.3	87.4	142.3	223.6
Cost of Goods Sold		--	11.2	0.1	15.9
GROSS PROFIT		25.3	76.2	142.2	207.6
Selling General & Admin Expenses, Total		16.7	39.7	34.9	27.6
R&D Expenses		93.1	140.1	126.9	182.8
Other Operating Expenses		-4.0	-0.8	-28.4	-35.1
OTHER OPERATING EXPENSES, TOTAL		105.9	179.0	133.4	175.2
OPERATING INCOME		-80.6	-102.9	8.8	32.4
Interest Expense		0.0	-0.1	-1.3	-0.2
Interest and Investment Income		4.3	1.4	6.5	5.6
Other Non-Operating Expenses, Total		-0.1	-3.1	-0.6	-1.4
Other Non-Operating Income (Expenses)		--	-5.8	--	--
Gain (Loss) on Sale of Investments		--	--	0.0	-0.1
EBT, INCLUDING UNUSUAL ITEMS		-76.4	-104.6	13.4	36.4
Earnings from Continuing Operations		-76.4	-104.6	13.4	36.4
NET INCOME		-76.4	-104.6	13.4	36.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-76.4	-104.6	13.4	36.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-76.4	-104.6	13.4	36.4

Report Data Issue

To contact ZEALAND PHARMA A/S, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.